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Introduction
The European e-Health Action Plan calls for inter-
operability between diﬀerent health computer systems
so that international data can be collected on the
quality of care and for research.1 Translational Re-
search and Patient Safety in Europe (TRANSFoRm) is
a European Union (EU)-funded international research
project aimed at delivering part of this agenda.2 The
aim of TRANSFoRm is to bring together existing
primary care databases with genetic and/or cancer
registry data repositories. These linked data sets can
then be used to conduct more sophisticated trans-
lational and biomedical research.
These three data sources, genetic data often in
biobanks, cancer registries and routinely collected
primary care data, have been widely used for research,
but are rarely combined. Genetic data have been
increasingly collected into biobanks since completion
of the mapping of the human genome between 2001
and 2004;3,4 although biological specimens have been
used for a longer period in pathology and forensic
science.5,6 Cancer registries have been in place for
some years7,8 and more recently have become inter-
national with the aim of understanding the epidemi-
ology of conditions,9 as well as the eﬀectiveness of
treatments.10 Primary care clinical recording in the
UKhas shifted decisively frompaper to computer over
recent years11,12 with routine data widely used for
research,13 but with relatively little linkage of data
beyond often disease-speciﬁc programmes in individ-
ual localities.
A central component of the TRANSFoRmproject is
the development of three-dimensional use-cases in
two clinical domains: type 2 diabetes and gastro-
oesophageal reﬂux disease (GORD). An epidemi-
ological study of people with type 2 diabetes aspires
to link genetic and primary care data sets and set outs
to explore the risk of complications and responses to
oral medications. In the GORD domain there are two
use-cases. The ﬁrst is a case-controlled study of the
association of GORD symptoms and the use of acid-
blocking drugs (speciﬁcally proton pump inhibitors;
PPIs) with developing Barrett’s disease and cancer of
the oesophagus. The second is a randomised con-
trolled trial of on-demand compared with continuous
PPI drug use, including monitoring patients’ symp-
toms and outcomes.
We set out to develop a survey instrument that
could determine if a database was able to meet the
requirements analysis and participate in linked data
research projects as set out in these use-cases.
ABSTRACT
Background Clinical data are collected for routine
care in family practice; there are also a growing
number of genetic and cancer registry data reposi-
tories. The Translational Research and Patient Safety
in Europe (TRANSFoRm) project seeks to facilitate
research using linked data from more than one
source. We performed a requirements analysis which
identiﬁed a wide range of data and business process
requirements that need to be met before linking
primary care and either genetic or disease registry
data.
Objectives To develop a survey to assess the
readiness of data repositories to participate in linked
research – the Transform International Research
Readiness (TIRRE) survey.
Method We develop the questionnaire based on
our requirement analysis; with questions at micro-,
meso- and macro levels of granularity, study-
speciﬁc questions about diabetes and gastro-oeso-
phageal reﬂux disease (GORD), and research track
record. The scope of the data required was exten-
sive. We piloted this instrument, conducting ten
preliminary telephone interviews to evaluate the
response to the questionnaire.
Results Using feedback gained from these inter-
views we revised the questionnaire; clarifying ques-
tions that were diﬃcult to answer and utilising skip
logic to create diﬀerent series of questions for the
various types of data repository. We simpliﬁed the
questionnaire replacing free-text responses with
yes/no or picking list options, wherever possible.
We placed the ﬁnal questionnaire online and en-
couraged its use (www.clininf.eu/jointirre/info.
html).
Conclusion Limited ﬁeld testing suggests that
TIRRE is capable of collecting comprehensive and
relevant data about the suitability and readiness of
data repositories to participate in linked data re-
search.
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geal diseases, primary health care, registries
The TIRRE survey instrument 209
Method
Overview
We report the development of a survey instrument to
collect the data identiﬁed in our requirements analy-
sis.14,15 In brief, this was part of the TRANSFoRm
project, whose relevant work tasks are summarised in
Table 1. Our requirements analysis identiﬁed data
requirements at the micro-, meso- and macro levels,
study-speciﬁc requirements and proposed that the
research track record was used as a sensitivity analysis
(Figure 1). Functionally, our micro-requirements
describe potential study data quality16 and its readi-
ness to incorporate into linked research; the meso-
level items to the technical readiness of the system
and data export systems. Key among the macro-
sociocultural issues are governance and regulatory
readiness, without which it is not possible to proceed.
Study-speciﬁc information, driven by the nature of
the data held and the sample size required to ﬂag
readiness for a particular study.
We adopted a two-phase approach to determine the
capability of primary care data repositories to link
to genotype data repositories and disease registries.
Phase one was the development of the survey instru-
ment reported here, and phase twowas data collection
and analysis.
TIRRE questionnaire content
We created a framework for the data needed to assess
the ﬁtness and preparedness of repositories to partici-
pate in linked research. The framework drew on
principles from interoperability, EPR architecture,
modelling and existing research data schema. Using
this framework, we developed a questionnaire that
could be used to collect data through a telephone
survey or be self-administered online. The framework
ensured that the survey data were collected at three
levels of granularity using standard headings for each
section of the questionnaire; additionally collecting
the study-speciﬁc data. The heterogeneity of the data
meant that we needed to extract comprehensive in-
formation about the data and how it was structured.
The ﬁrst section, the micro level was concerned with
the data source, the data itself, metadata, the potential
for linkage or achieving semantic interoperability
between data sources,17 and details of how many
studies have been published using the data. The second
section, the meso level, explored data extraction,18 the
architecture of the computerised medical record
Table 1 Details of the TRANSFoRm work tasks
Description of work tasks (WT) 6.1 and 6.2 of the TRANFoRm project:
WT 6.1: Requirements analysis of EHRs
1. Using the results of the EHR capacity study within the EGPRN and ESPCG networks (WT1.1)
we will conduct an in-depth study of the most common EHR systems used in Europe to
examine the availability of API details. The scope of the study will include patient held records,
which may hold substantially less coded and structured data. These will include Microsoft and
Google patient record systems – and countries where health cards are used.
2. We will conduct a parallel in-depth study of data repositories that can be used for clinical
trials. We will look to identify local, EHR brand-speciﬁc and health-system access points to
primary care data. The types of data access points we might be able to run queries on include:
(1) billing or performance indicator extracts of routine data; (2) sentinel networks or research
network database; and (3) national data extract systems with closed API. These may provide
pragmatic quick win access to primary care data while a longer term access is being developed.
WT 6.2: Requirements analysis of genotype data repositories
We will conduct a parallel in-depth study of (genotype) clinical data repositories across
Europe and their potential use for clinical research. The scope of the study will include
structured genotype data and potential integration points with patient health care for
biomedical and translational clinical research. Genotype data is normally held by biobanks or
other research organisations either as sample identiﬁcation information or speciﬁc codes for
single nucleotide polymorphisms (SNPs).
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(CMR) and other data repositories,19 audit trails and
the size of the database. Finally, the third section, the
macro level, explored issues relating to the nature of
the health system, sociocultural factors and issues
relating to funding, the purpose and restrictions on
the use of the data. Study-speciﬁc questions make up
the ﬁnal part of the survey instrument (Figure 1).20
Piloting the TIRRE questionnaire with
the ﬁrst ten repositories
We initially contacted 10 sites who were interested in
participating in the TRANSFoRm project by email, if
available, and followed this up with telephone calls.
We collected data through a structured telephone inter-
view. These 10 repositories were based throughout
Europe. These ﬁrst 10 sites were also stakeholders in
our requirements analysis.18
The pilot sample
The pilot sample was comprised of mainly primary
care databases (50%, n= 5); this was principally because
we had better links to these databases and this made
conducting the telephone pilot easier. The sample
included epidemiological cohorts (20%, n = 2), dis-
ease registries (20%, n = 2) and a genomic database
(10%, n = 1). All of the organisations questioned held
data for the purpose of research.We set out to recruit a
representative sample.
Development of the online
questionnaire using skip logic
We then developed and introduced an online version
of our survey instrumentwhilst continuing to oﬀer the
telephone method in parallel for repositories that
preferred to pass on information this way. The survey
was comprehensive and consisted of 160 questions.
We used a software package fromSurveyMonkeyTM to
create and develop the online questionnaire. To avoid
Figure 1 Detail of the questionnaire schema. At the data-source level, A is completed by genetic databases
only
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unnecessary repetition in data collection and to ensure
that only relevant information for each type of reposi-
tory was collected, the online version was designed
using skip logic. Skip logic also has the beneﬁt of
making the survey instrument more streamline, re-
ducing the number of questions each respondent is
required to answer (Table 2).
Ethical considerations
There was no formal ethics board review. This survey
only seeks to report information about the capacity
and capability of information sources to be combined
to conduct research studies. The survey does include a
self-declaration that the data held were subject to an
ethical process. We did not consider any issues of
consent or privacy, beyond exploring a site’s track
record for studies and that there was a mechanism for
obtaining consent for any speciﬁc study.
Results
The pilot sample
Seven of the ten sites conﬁrmed that there were no
restrictions on the use of their data for ethically
approved research studies and all had had studies
completed and published using their data source.
Seven were able to conﬁrm that their data sets could
be used for cross-sectional studies, three had the
ability to link to other genetic databases and three
had access to other methods of data collection such as
social security systems. Five of the repositories required
additional patient consent to be completed to use their
data for research; of these, four conﬁrmed that indi-
vidual consent was not required if strong identiﬁers
were removed. The same ﬁve stated that individual
consent was required to: (1) link single nucleotide
polymorphisms (SNPs) to phenotype or primary care
data studies, and (2) identify individuals participating
in cohort, cross-sectional studies or for recruitment
into trials. Eight repositories were able to conﬁrm that
there was a local or network-speciﬁc protocol for
ethical approval that needed to be followed for their
collections, and seven said that there were restrictions
on the use of their data for ethically approved research
studies. Seven of the repositories conﬁrmed their data
source did not employ a unique identiﬁer to allow
linkage between primary care, hospital and national
health data. The majority held historical data (e.g.
from a patient’s birth) and all except one could
provide age-sex proﬁle data from their source.
The sample was drawn as follows: there were ﬁve
primary care sites, one from each of France, Germany,
Denmark, Italy and Finland. France also provided two
epidemiological cohorts; there was a genomics database
from the UK and a disease registry from Switzerland
completed the sample.
Table 2 Categories of data collection and min-to-max number of questions depending on
the extent to which skip logic is utilised
Level Category Primary
care data
Genetic
database
Cancer
registry
Others
(social care
data,
cohorts)
Number of
questions
Micro Data source 30–46 36–54 30–46 33–51 54
Data interoperability 30–43 31–43 31–43 31–43 43
Subtotal 60–89 67–97 61–89 64–94 97
Meso Record system 5–30 5–30 5–30 5–30 30
Macro Organisational 15–15 15–15 15–15 15–15 15
Sociocultural 6–10 6–10 6–10 6–10 10
Subtotal 21–25 21–25 21–25 21–25 25
Study Use-case speciﬁc 5–8 5–8 5 –8 5–8 8
Total Min: 91;
Max: 152
Min: 98;
Max: 160
Min: 92;
Max: 152
Min: 95;
Max: 157
160
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Feedback and developing the
questionnaire
The initial telephone interview took around 1.5 hours
to complete. This was deemed too long, felt onerous
for the person supplying the information and pro-
vided no obvious beneﬁt to them. With this in mind,
we sought to improve the questionnaire by three
methods. First, we analysed the 104 questions that
had a yes/no response and explored whether they are
more likely to be positive in a database that is eligible
to complete the use-case. Second, we looked at the
multiple response questions, simplifying them into
single response questions, we looked for common
categories that allowed us to reduce the number of
free-text responses and investigated the skip logic
sections. Third, we removed questions that did not
discriminate between use-case eligible or not. The
study team then reviewed questions for potential
removal from the TIRRE survey instrument, as some
non-discriminatory data may still be useful and
required (e.g. all databases need to be able to state
the size of their population). As a result of the above
activities, we have been able to remove the questions
that we do not think are essential, reducing the
number to 139.
For the second version of the TIRRE survey instru-
mentwe removed ‘Don’t know’ as an answer option in
order to prompt a yes or no response. Many questions
from the ﬁrst version of the TIRRE survey were
combined and rewritten for the second version in
order to simplify answer options.
To improve the identiﬁcation of data sources with
greater potential for generating linkages we added a
newQuestion 4 ‘Does the data source provide national
coverage?’, and to assess the readiness of a data source
to participate in a speciﬁc study we added new
questions ‘From ﬁrst receiving a formal request for
study data, how long do you anticipate it would take
you to export the data to researchers?’ (Question 136
in TIRRE2) and ‘In the last 12 months what is the
mean time taken from receiving any formal request for
study data through to exporting that data to re-
searchers?’ (Question 137 in TIRRE2). We removed
Questions 33–36 (asking for text data about the actual
publications) as we felt this data could be asked for or
checked subsequently if necessary. In order to simplify
the responses we rewrote many questions. For example,
we changed Question 38 (the original Question 42 in
TIRRE1) from ‘How long does it typically take to get
ethical approval?’ to ‘Does it typically take less than 6
months to get ethical approval’. This process is subject
to on-going development.
Summary results
We created a screening tool to assess the readiness of
clinical data repositories around the world to partici-
pate in linked research. By utilising skip logic we can
streamline the TIRRE tool, making it more speciﬁc to
each type of stakeholder and reducing the number of
questions needed (Tables 3 and 4). Questions selected
for the ﬁnal online version were judged to be essential
to ascertain key information about the suitability of
data repositories from at least two members of the
same group.21,22
Sensitivity analysis
Eight of the ten data-providing stakeholders could
quote peer review publications produced from their
data and indexed in PubMed.23 Four estimated that
between 30 and 100 peer review articles had been
published in the last ﬁve years; of the remaining six,
two estimated that between 11 and 20 articles had been
published, one estimated that 2 to 5 articles had been
published, and one stated that no publications had
been generated based on their data.
Table 3 Summary of issues for data repositories taking part in the initial pilot
Project stakeholder Speciﬁc
information needs
Best source of
information needed
Planned method
of delivery
Timing
considerations
Data providers 1. Return on
investment of time
– studies, funding
2. Strategic interest
Who will get a
funded study?
Track record of
researcher
Engage once
beneﬁts
Have standard
processable outputs
readily available
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Discussion
Principal ﬁndings
The TIRRE instrument is a screening tool to assess
both the potential of a database to take part in use-
cases and the feasibility of conducting linked research;
although we recognise that further testing may be
required before a data source participates in a study.
The TIRRE survey systematically collects the extensive
amount of information required to assess readiness to
participate in studies linking primary care and either
genetic databases or cancer registry data. It is based on
a requirements analysis. Although we had diﬃculty in
getting databases to complete the questionnaire, when
we did get a response the completeness of the infor-
mation gathered was high and proved useful in iden-
tifying their potential to participate in linked research.
There are currently no other international sites avail-
able to enable brokerage between databases willing to
participate in research.
Implications of the ﬁndings
The TIRRE survey is the best ﬁrst step towards
assessing the ‘linkability’ of databases in one locality
and the extent to which a study might be run across
several localities. It has the potential to measure
readiness in several dimensions:
. data quality readiness frommicro-level information
. record readiness and the technical ability of the
computer systems that hold the data to export it
reliably and
. governance readiness, including any information
about sociocultural barriers to utilisation.
Collectively, these dimensions inform about the readi-
ness to scale the study beyond a single database –
which we term scalability readiness. However, any
initial screening process may need to be followed up
by a detailed assessment ofwhether the data set needed
for a given study can be elicited from the data
repositories.
Table 4 Categories of data collection and min-to-max number of questions after
application of the skip logic
Number of questions
Primary care Cancer registry Genetic Overall
Analysis by
respondent
Should Mean Response Mean Response Mean Response Mean Response
Categorical
questions
n n % n % n % n %
Data source 35 22.41 64 24.00 69 25.00 71 23.39 67
Data inter-
operability
31 29.34 95 28.80 93 26.25 85 28.54 92
Micro level 66 51.76 78 52.80 80 51.25 78 51.93 79
Meso level/
record
system
12 3.10 26 2.33 19 2.67 22 2.80 23
Organ-
isational
15 15.00 100 15.00 100 15.0 92 14.73 98
Socio-
cultural
6 5.17 86 5.47 91 4.50 75 5.11 85
Macro level 21 20.17 96 20.47 97 18.25 87 19.84 94
Overall 104 79.90 76.82 80.60 77.50 83.27 80.07 80.76 77.66
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Comparison with the literature
It is possible to draw comparisons between the com-
plexity of this task and the existing successful projects
that involve linking data. However, the successful data
repositories in the UK have all been based on a single
brand of general practice electronic health record (EHR)
system. The General Practice Research Database
(GPRD), recently renamed the Clinical Practice Re-
search Datalink (CPRD), extracts data from a brand
called In-Practice Systems (INPS) Vision, although it
is set to expand its coverage. TheHealth Improvement
Network (THIN) also collects data from INPS.24 Q-
Research takes data from the EMIS EHR25 and other
sentinel networks all follow the same pattern. Even the
relatively simple task of linking data from this small
number of brands of computer within the UK has
proved challenging, in terms of both creating a sum-
mary care record26 and developing a common data-
extraction system.27 Overall, we are unable to ﬁnd
anything similar to TRANSFoRm in academia. Wider
use of ontologies may provide a framework for better
information sharing.28,29
Little has beenwritten about the concept of research
readiness and its importance for studies requiring data
from more than one source. Early conceptual models
for primary care research networks focused on the
structures, process and outcomes – without thinking
of readiness as a key concept.30 Research readiness has
been introduced in the UK at the individual practice
level; although this is through a system of self-
accreditation.31 Internationally, the Electronic Health
Record for Clinical Research (EHRCR) Project has
produced a functionality proﬁle which outlines the
high-level requirements necessary for EHR systems to
be considered as a reliable data source in line with the
appropriate regulations governing clinical research.
This proﬁle will be used as the basis for the certiﬁ-
cation of EHR systems used in clinical research with
the aim of increasing the level of comfort of prac-
titioners, the research community and regulators with
the practice of storing source data in EHR systems;32
although this approach does not appear to have been
adopted widely.
Limitations of the method
An initial survey, provided from a previous work
package, provided limited information on the suit-
ability and readiness of databases.17 Redeﬁnition of
the variables required for these databases enabled us to
conduct a further survey. There was no real incentive
for data repositories to supply us with the data
required, as there was not a reciprocal oﬀer of beneﬁt.
Successful completion of the survey was a lengthy
process, taking in excess of 1 hour. As a consequence,
our results inevitably underestimate the number of
sites where this type of research can be conducted.
Inevitably, simpliﬁcation needed to construct eﬀec-
tive middleware. The use-cases have developed ap-
propriate but complex models. The provenance of
data deﬁned within the work package has been broad,
seeking to map the provenance of data from the
original observation, but going beyond the scope of
the study use-cases.
Finally, our approach was framed by the English
context,33 and communication in English. However,
in mitigation we also have a European perspective on
health system data.34
Call for further research
We need to conduct test–retest studies to assess the
reliability of the survey instrument. We should con-
duct simulated and real studies with data extractions
to test its validity.
Conclusions
A large complex set of data is needed to know if it will
be possible to link primary care and either a disease
registry or genetic database. This set of data can either
be classiﬁed by the level of granularity or as a business
or data requirement. The TIRRE instrument is evolv-
ing into a tool that can be used to assess general
suitability and readiness to participate in linked re-
search studies.
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